September 21, 2025: Litigation focus continues to shift from gastroparesis claims, which have faced challenges in demonstrating direct causation versus diabetes complications, toward vision loss cases involving non-arteritic anterior ischemic optic neuropathy (NAION)
When it comes to health technologies that are billed as innovative the Left have always been suckers
Hybios focus on large-scale API production means that small batch trial orders and custom packaging are not standard services
Insurance and Lab Testing Ros insurance concierge handles approvals for brand-name GLP-1s, which is genuinely valuable when a covered Wegovy prescription can cost you a copay instead of four figures
Declining estrogen levels can trigger a cascade of metabolic changes that make traditional weight loss approaches not work as well as they did before
notably, vape exposure blunted macrophage basal respiration, an effect partially rescued by CFTR modulator therapy (ETI), while concurrently increasing glycolytic metabolism, a change unaffected by ETI treatment (Wisniewski et al., 2025)